VHL and melanoma: Next, we aimed to determine the impact of VHL loss on NK cell immunosurveillance of metastatic tumor cells in vivo and injected syngeneic B16F10 melanoma cells intravenously into VHL KO mice as well as the corresponding WT littermates and analyzed the number of pulmonary metastases 2‐week postinjection.